Veritas In Silico Inc. ( ($JP:130A) ) has issued an update. Veritas In Silico has filed a substance patent application in Japan for a ...

Top large-cap gainers for Dec. 15–19 were led by Rivian, Moderna, and BioMarin, rising on product/software updates, vaccine ...

The latest announcement is out from Targovax ASA ( (GB:0RIS) ).

Here are seven biopharma-related trends for 2026 that have emerged from GEN interviews with experts and other industry stakeholders, and from reviews of reports and public statements.

BioNTech SE (NASDAQ:BNTX) is one of the Stocks That Will Go To The Moon in 2026. On December 18, BioNTech SE (NASDAQ:BNTX) ...

An illustration of a dual-capped mRNA and a capped circular RNA to augment cap-dependent translation initiation using branched topology. Chen et al. have developed a precise chemo-enzymatic method to ...

Get the live share price of Moderna Inc (MRNA), including intraday charts, historical performance, key financials, and market updates. Track the latest US stock market activity.

Merck declines its option on Evaxion's EVX-B2 gonorrhea vaccine, leaving global rights with Evaxion and no change to its cash ...

The Portfolio returned 7.33% gross, significantly outperforming the MSCI World Health Care Index's 3.12% return. Click here ...

Stocks end the week little changed. Meanwhile, Rivian jumps 22%, while Nike falls.